SCHEMBL8286360

SCHEMBL8286360

CNC(=O)CSc1cc(C(F)(F)F)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.55
ALDH1A1 P00352 4/20 0.38
GAA P10253 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
POLB P06746 3/20 0.37
MAPT P10636 3/20 0.37
TP53 P04637 2/20 0.37
HTT P42858 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 1/20 0.37
RAB9A P51151 1/20 0.36
USP2 O75604 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287836 0.92 PDE11A (0.56) PDE11AALDH1A1POLBMAPTTP53
SCHEMBL5871578 0.91 PDE11A (0.58) PDE11AALDH1A1GAAMEN1KMT2A
SCHEMBL8286363 0.89 PDE11A (0.56) PDE11AALDH1A1GAAMEN1KMT2A
SCHEMBL8287106 0.89 PDE11A (0.54) PDE11AALDH1A1GAAL3MBTL1POLB
SCHEMBL8287819 0.87 PDE11A (0.53) PDE11AALDH1A1GAAMEN1KMT2A
SCHEMBL7042467 0.87 PDE11A (0.60) PDE11AALDH1A1GAAMEN1KMT2A
SCHEMBL8287112 0.85 PDE11A (0.57) PDE11AALDH1A1GAAMEN1KMT2A
SCHEMBL8287366 0.85 PDE11A (0.57) PDE11AALDH1A1GAAMEN1KMT2A
SCHEMBL8287191 0.84 PDE11A (0.59) PDE11AALDH1A1GAAMEN1KMT2A
SCHEMBL5871955 0.84 PDE11A (0.56) PDE11AALDH1A1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed